Niti R Aggarwal1, Adela Drozdova2, J Wells Askew1, Bradley J Kemp3, Panithaya Chareonthaitawee4. 1. Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. 2. International Clinical Research Center - Center of Molecular Imaging, St. Anne's University Hospital Brno, Brno, Czech Republic. 3. Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. 4. Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA. chareonthaitawee.panithaya@mayo.edu.
Abstract
BACKGROUND: Treadmill exercise nitrogen-13 ((13)N)-ammonia positron emission tomography (PET) has logistical challenges and limited literature. We aimed to assess its feasibility, image quality, and diagnostic accuracy in obese and nonobese patients. METHODS AND RESULTS: Between 2009 and 2012, 10,804 patients were referred for myocardial perfusion imaging, including 300 for treadmill PET, of whom 265 were included in this study. Treadmill testing and PET were performed using standard procedures. Image quality, perfusion, and summed stress score (SSS) were assessed. Invasive coronary angiography was performed within 90 days of PET in 43 patients. Mean ± SD body mass index (BMI) was 35.7 ± 7.7 kg/m(2) (range 19.5-63.5 kg/m(2)). Feasibility of treadmill (13)N-ammonia PET was 100%. Exercise duration was less for obese patients than nonobese patients (P < .001). Image quality was rated good for 96.9% of obese and 100% of nonobese patients. For all patients, sensitivity was 86.4% and specificity was 74.4%. Diagnostic accuracy did not change significantly with increasing BMI. SSS remained significant in predicting angiographic coronary artery disease after adjustment for age, sex, and Duke treadmill score. CONCLUSIONS: Treadmill (13)N-ammonia PET is highly feasible, yields good image quality, and has moderately high diagnostic accuracy in a small subset of obese and nonobese patients who are deemed able to perform treadmill exercise.
BACKGROUND: Treadmill exercise nitrogen-13 ((13)N)-ammonia positron emission tomography (PET) has logistical challenges and limited literature. We aimed to assess its feasibility, image quality, and diagnostic accuracy in obese and nonobese patients. METHODS AND RESULTS: Between 2009 and 2012, 10,804 patients were referred for myocardial perfusion imaging, including 300 for treadmill PET, of whom 265 were included in this study. Treadmill testing and PET were performed using standard procedures. Image quality, perfusion, and summed stress score (SSS) were assessed. Invasive coronary angiography was performed within 90 days of PET in 43 patients. Mean ± SD body mass index (BMI) was 35.7 ± 7.7 kg/m(2) (range 19.5-63.5 kg/m(2)). Feasibility of treadmill (13)N-ammonia PET was 100%. Exercise duration was less for obesepatients than nonobese patients (P < .001). Image quality was rated good for 96.9% of obese and 100% of nonobese patients. For all patients, sensitivity was 86.4% and specificity was 74.4%. Diagnostic accuracy did not change significantly with increasing BMI. SSS remained significant in predicting angiographic coronary artery disease after adjustment for age, sex, and Duke treadmill score. CONCLUSIONS: Treadmill (13)N-ammonia PET is highly feasible, yields good image quality, and has moderately high diagnostic accuracy in a small subset of obese and nonobese patients who are deemed able to perform treadmill exercise.
Authors: Y Yonekura; N Tamaki; M Senda; R Nohara; H Kambara; Y Konishi; H Koide; S A Kureshi; H Saji; T Ban Journal: Am Heart J Date: 1987-03 Impact factor: 4.749
Authors: Robert B McCully; Veronique L Roger; Douglas W Mahoney; Kelli N Burger; Roger L Click; James B Seward; Patricia A Pellikka Journal: J Am Coll Cardiol Date: 2002-04-17 Impact factor: 24.094
Authors: M G Levine; A W Ahlberg; A Mann; M P White; C C McGill; C Mendes de Leon; J M Piriz; D Waters; G V Heller Journal: J Nucl Cardiol Date: 1999 Jul-Aug Impact factor: 5.952
Authors: Todd D Miller; David O Hodge; Timothy F Christian; James J Milavetz; Kent R Bailey; Raymond J Gibbons Journal: Am J Med Date: 2002-03 Impact factor: 4.965
Authors: Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom Journal: J Nucl Cardiol Date: 2006 Jan-Feb Impact factor: 5.952
Authors: Benjamin J W Chow; Owayed M Al Shammeri; Rob S Beanlands; Li Chen; Robert A deKemp; Jean DaSilva; Terrence D Ruddy Journal: Can J Cardiol Date: 2009-07 Impact factor: 5.223